Description: FDA APPROVES AVASTIN_A TARGETED THERAPY FOR FIRST-LINE METASTATIC COLORECTAL CANCER PATIENTS. First Anti-Angiogenesis Treatment Approved for Treating Cancer. SOUTH SAN FRANCISCOCalif. - February 272004 - GenentechInc. ( in a randomizedPhase III study of patients with metastatic colorectal cancer.

Category: Metastatic Colorectal Cancer

Url: http://www.prnewswire.com/mnr/avastin/11707

Date: Oct 7, 2005

Current Rating: 0.00

Clicks/Hits Received: 0